Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -1067.75% is in line with its 5-year average of -1136.63%, near the high end of its 5-year range (-8262.90%–43.19%).
2.33% below its 12-month average of -1043.46%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 43.19%.
EBITDA MARGIN
-1067.75%
EBITDA MARGIN AVG TTM
-1043.46%
EBITDA MARGIN AVG 3Y
-1480.86%
EBITDA MARGIN AVG 5Y
-1136.63%
EBITDA MARGIN AVG 10Y
-580.38%
EBITDA MARGIN AVG 15Y
-387.54%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.33%
CURRENT VS 3Y AVG
+27.90%
CURRENT VS 5Y AVG
+6.06%
CURRENT VS 10Y AVG
-83.97%
CURRENT VS 15Y AVG
-175.52%
CURRENT VS 20Y AVG
N/A
Precigen, Inc.
Market Cap
$2.69B
EBITDA Margin
-1067.75%
TTM Avg
-1043.46%
3Y Avg
-1480.86%
5Y Avg
-1136.63%
Market Cap
$2.70B
EBITDA Margin
17.42%
TTM Avg
19.36%
3Y Avg
20.74%
5Y Avg
18.34%
Market Cap
$2.71B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.66B
EBITDA Margin
11.88%
TTM Avg
11.88%
3Y Avg
7.44%
5Y Avg
-2.29%
Market Cap
$2.77B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$2.61B
EBITDA Margin
11.52%
TTM Avg
13.31%
3Y Avg
15.86%
5Y Avg
16.56%
Market Cap
$2.60B
EBITDA Margin
-1001.92%
TTM Avg
-694.29%
3Y Avg
-672.56%
5Y Avg
-672.56%
Market Cap
$2.60B
EBITDA Margin
-270.04%
TTM Avg
-444.88%
3Y Avg
-365.27%
5Y Avg
-89273.54%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precigen, Inc. (PGEN) | $2.69B | -1067.75% | -1043.46% | -1480.86% | -1136.63% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 17.42% | 19.36% | 20.74% | 18.34% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 11.88% | 11.88% | 7.44% | -2.29% |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 3.20% | -0.69% | -3.43% | -1.09% |
| TransMedics Group, Inc. (TMDX)vs › | $2.77B | 22.42% | 17.70% | -0.76% | -37.34% |
| Neogen Corporation (NEOG)vs › | $2.61B | 11.52% | 13.31% | 15.86% | 16.56% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | -1001.92% | -694.29% | -672.56% | -672.56% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -270.04% | -444.88% | -365.27% | -89273.54% |
| Privia Health Group, Inc. (PRVA)vs › | $2.56B | 2.08% | 1.74% | 1.01% | -2.48% |
Gross Margin
37.0%
EBITDA Margin
-1067.8%
Operating Margin
-1100.8%
Net Margin
-184.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 43.19% |
| 2026-03-31 | -21.05% |
| 2025-12-31 | -449.70% |
| 2025-09-30 | -1152.57% |
| 2025-06-30 | -3637.15% |
| 2025-03-31 | -1638.11% |
| 2024-12-31 | -2340.76% |
| 2024-09-30 | -2160.34% |
| 2024-06-30 | -8262.90% |
| 2024-03-31 | -2142.54% |
| 2023-12-31 | -1773.21% |
| 2023-09-30 | -1398.62% |
| 2023-06-30 | -1099.43% |
| 2023-03-31 | -1175.96% |
| 2022-12-31 | -1138.74% |
| 2022-09-30 | -34.63% |
| 2022-06-30 | -719.20% |
| 2022-03-31 | -367.04% |
| 2021-12-31 | -387.76% |
| 2021-09-30 | -543.98% |
| 2021-06-30 | -594.91% |
| 2021-03-31 | -842.62% |
| 2020-12-31 | 38.07% |
| 2020-09-30 | -81.50% |
| 2020-06-30 | -23.16% |
| 2020-03-31 | -39.51% |
| 2019-12-31 | -637.69% |
| 2019-09-30 | -184.85% |
| 2019-06-30 | -86.97% |
| 2019-03-31 | -223.38% |
| 2018-12-31 | -761.73% |
| 2018-09-30 | -179.27% |
| 2018-06-30 | -91.08% |
| 2018-03-31 | -91.44% |
| 2017-12-31 | -23.66% |
| 2017-09-30 | -79.88% |
| 2017-06-30 | -51.03% |
| 2017-03-31 | -44.62% |
| 2016-12-31 | -55.81% |
| 2016-09-30 | -46.62% |
| 2016-06-30 | -32.75% |
| 2016-03-31 | -80.31% |
| 2015-12-31 | -69.53% |
| 2015-09-30 | -5.76% |
| 2015-06-30 | -30.34% |
| 2015-03-31 | -246.90% |
| 2014-12-31 | -49.58% |
| 2014-09-30 | -56.38% |
| 2014-06-30 | -136.71% |
| 2014-03-31 | -204.57% |
| 2013-12-31 | -223.74% |
| 2013-09-30 | -167.45% |
| 2013-06-30 | -183.32% |
| 2013-03-31 | -305.21% |
| 2012-12-31 | -154.67% |
| 2012-09-30 | -493.03% |
| 2012-06-30 | -705.32% |
| 2012-03-31 | -1435.72% |
